Biophytis SA (BPTSY)
7.09
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Biophytis Accounts Payable (Quarterly): 5.960M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.960M |
| June 30, 2023 | 4.033M |
| June 30, 2023 | 4.033M |
| December 31, 2022 | 7.442M |
| June 30, 2022 | 10.54M |
| June 30, 2022 | 10.54M |
| December 31, 2021 | 8.612M |
| June 30, 2021 | 9.446M |
| June 30, 2021 | 9.446M |
| December 31, 2020 | 9.821M |
| June 30, 2020 | 10.79M |
| Date | Value |
|---|---|
| June 30, 2019 | 5.962M |
| March 31, 2019 | 5.312M |
| June 30, 2018 | 3.376M |
| June 30, 2018 | 3.376M |
| December 31, 2017 | 2.880M |
| June 30, 2017 | 1.582M |
| June 30, 2017 | 1.582M |
| December 31, 2016 | 2.030M |
| June 30, 2016 | 1.918M |
| June 30, 2016 | 1.918M |
| December 31, 2015 | 0.7664M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
4.033M
Minimum
Jun 2023
10.79M
Maximum
Jun 2020
8.052M
Average
9.029M
Median
Accounts Payable (Quarterly) Benchmarks
| DBV Technologies SA | 18.08M |
| Cellectis SA | 16.05M |
| Genfit SA | 11.55M |
| Adaptimmune Therapeutics PLC | 6.587M |
| Akari Therapeutics PLC | 3.208M |